Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Advanced biopolymer nanocomposites for real-time biosurveillance and defense against antimicrobial resistance and viral threats.

PMID: 40936947 · 2025

JournalRSC advances
Year2025
PMID40936947

Abstract

Antimicrobial resistance (AMR) presents an ever increasing challenge to health globally. Until now, all conventional antibiotics and antivirals are struggling to keep up with minimum efficacy and eradication rate in both civilian and military contexts. The purpose of this review is to compile all current research on the use of functionalized biopolymer nanocomposites, highlighting them as the next-generation of antimicrobial platforms. The emphasis is placed on natural and synthetic biopolymers

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.